Formulation evidence map · Published July 22, 2026 · Sources checked July 22, 2026

DermaLuxe research kit overview

DermaLuxe is a catalog kit containing multiple distinct research materials. No primary publication cited here evaluated this exact combination.

Evidence boundary: ingredient studies do not establish the behavior of this exact formulation. The catalog product is offered only for lawful nonclinical laboratory research and is not for human or veterinary use.

What is DermaLuxe kit?

The ingredient literature spans GHRH receptor signaling, ghrelin-receptor secretagogue pharmacology, and copper-peptide extracellular-matrix research.

Research category
Formulations & research kits
Study models represented
Ingredient-level biochemical, animal, and selected human studies
Names in the literature
DermaLuxe Series
Primary boundary
No direct formulation evidence, interaction data, or kit-level outcome data.

What does the selected evidence support?

The presence of ingredient studies does not establish a combined dermatologic, regenerative, or other outcome.

Primary sources

  1. Maquart et al. (1993) — GHK-Cu animal research; not a kit study. DOI: 10.1172/JCI116842
  2. Raun et al. (1998) — Ipamorelin pharmacology; not a kit study. DOI: 10.1530/eje.0.1390552
  3. Ranke et al. (1986) — GRF(1-29)-amide research; not a kit study. DOI: 10.1007/BF02429048

Ingredient evidence reviews

Research literature and product documentation are different

A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.

Browse the COA library · Read the research-use policy

Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.